- $7.15bn
- $5.86bn
- $1.61bn
UiPath Inc expected to post earnings of 7 cents a share - Earnings Preview
RCS - GMO GlobalSign - GMO GlobalSign and airSlate Announce Partnership
Brief: Uipath Announces Partnership With Apprio To Deliver Ai-Powered Automation Solutions For Midmarket Healthcare Organizations
Brief: Uipath Inc & Teradata Announced A Partnership
Analysis: For retail investors, jumping on Arm's blockbuster IPO is a risky business
US STOCKS-S&P, Nasdaq fall as Apple drags, jobless claims data fuels rate jitters
US STOCKS-S&P, Nasdaq fall as Apple drags, jobless claims data fuels rate jitters
US STOCKS-S&P, Nasdaq fall as Apple drags, jobless claims data fuels rate jitters
U.S. STOCKS ON THE MOVE-Kodiak Sciences, Intensity Therapeutics, Inovio Pharma
U.S. STOCKS ON THE MOVE-Kodiak Sciences, Intensity Therapeutics, Inovio Pharma
U.S. STOCKS ON THE MOVE-Nurix Therapeutics, Designer Brands
Refinitiv Newscasts - U.S. Morning Call: S&P 500 and Nasdaq futures slip on inflation concerns as key Fed officials set to speak today
UiPath gains on upbeat forecast, Q2 beat
U.S. RESEARCH ROUNDUP-Aerovironment, Hubspot, Oracle
UiPath Inc reports results for the quarter ended in July - Earnings Summary
Brief: UiPath Q2 Revenue USD 287 Million Vs. IBES Estimate USD 282.1 Million
UiPath Inc expected to post earnings of 3 cents a share - Earnings Preview
Brief: Uipath Announces New Connectors For Google Ai And Google Workspace At Google Cloud Next 2023 Conference
CEO, Effective As Of January 31, 2024